Migraine News and Research

Latest Migraine News and Research

People with metabolic syndrome may be at higher risk for second stroke, death

People with larger waistlines, high blood pressure and other risk factors that make up metabolic syndrome may be at higher risk for having a second stroke and even dying than people who do not have metabolic syndrome, according to a meta-analysis published in the July 28, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.

28 Jul 2021

Foods high in flavonoids may lower risk of cognitive decline

A new study shows that people who eat a diet that includes at least half a serving per day of foods high in flavonoids like strawberries, oranges, peppers and apples may have a 20% lower risk of cognitive decline.

28 Jul 2021

Dietary alteration of certain fatty acids can reduce severity of headaches

Migraine is one of the largest causes of disability in the world. Existing treatments are often not enough to offer full relief for patients.

2 Jul 2021

High omega 3 diet associated with reduction of headaches

Eating a diet rich in omega 3 (n-3) fatty acids reduces the frequency of headaches compared with a diet with normal intake of omega 3 and omega 6 (n-6) fatty acids, finds a study published by The BMJ today.

2 Jul 2021

Study offers a very hopeful message for individuals struggling with migraines

A new study from researchers at the University of Toronto found that 63% of Canadians with migraine headaches are able to flourish, despite the painful condition.

24 Jun 2021

New consensus statement on sport-related concussion aims to help doctors provide optimal medical care

Strict rest after a sports related concussion slows recovery and may prolong symptoms, says a consensus statement drawn up by a US expert panel on how best to treat and manage the condition, and published in the British Journal of Sports Medicine.

17 Jun 2021

Free virtual event highlights new inventions on point-of-care medical technologies

Life sciences entrepreneurs, researchers and investors working to shape the future of point-of-care medical technologies will gather next week for a free virtual event that will highlight new inventions and connect participants to resources to advance their work.

10 Jun 2021

Clinical trial looks at cannabis as a potentially effective treatment for acute migraines

Allison Knigge was in elementary school when she started to experience migraines. They continued to get progressively worse as time went on, especially after the birth of her son.

20 May 2021

Study reveals four coagulation measures associated with migraine susceptibility

Nearly 15 percent of the U.S. population experiences migraine. One subtype of migraine that is not well understood is migraine with aura (MA).

19 May 2021

UIC researcher finds potential new way to treat chronic migraine

By discovering a potential new cellular mechanism for migraines, researchers may have also found a new way to treat chronic migraine.

5 May 2021

ASPS survey reveals COVID-19's impact and patient demand for plastic surgery

The American Society of Plastic Surgeons (ASPS) - the world's largest plastic surgery organization, representing nearly 8,000 members - today released the 2020 results of the organization's annual procedure survey coupled with national consumer research reflecting trends during the COVID-19 era to help predict what 2021 will bring.

28 Apr 2021

Survey: CDC's opioid prescribing guideline for pain treatment should be revoked

The CDC's opioid prescribing guideline has failed to reduce addiction and overdoses, significantly worsened the quality of pain care in the United States and should be revoked, according to a large new survey of patients and healthcare providers by Pain News Network, an independent, non-profit news organization.

26 Apr 2021

Some COX inhibitors/NSAIDs increase COVID-19 severity

A startling new preprint research paper posted to the medRxiv server warns against the use of commonly used non-steroidal anti-inflammatory drugs (NSAIDs) belonging to the category of cyclooxygenase inhibitors (COX inhibitors) in patients with coronavirus disease 2019 (COVID-19).

22 Apr 2021